We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients
2 min Read
Share

Aprameya Engineering Limited, a company specialising in healthcare infrastructure and equipment, is set to launch its initial public offering (IPO) on July 25, 2024. This blog offers a comprehensive analysis of the IPO to help you make informed investment decisions.

About Aprameya Engineering

Established in 2003, Aprameya Engineering caters to the growing demand for critical healthcare facilities. They offer a turnkey solution, encompassing:

  • Installation and maintenance of critical care units (ICU, NICU, PICU)
  • Operation theatres
  • Prefabricated structure wards
  • High-value medical equipment supplies

Their clientele includes private hospitals, government institutions, and medical practitioners.

Aprameya Engineering IPO fundamentals

  • Issue Type: Book Built Issue
  • Issue Size: ₹ 29.23 Crore
  • Fresh Issue: Entirely fresh issue of 50,40,000 shares
  • Offer Period: July 25, 2024 - July 29, 2024
  • Expected Allotment: July 30, 2024
  • Listing Venue: NSE SME (tentative listing date: August 1, 2024)
  • Price Band: ₹ 56 - ₹ 58 per share
  • Minimum Lot Size: 2,000 Shares (Retail Investors: ₹ 1,16,000 minimum investment)
  • HNI Minimum Lot: 2 Lots (4,000 Shares - ₹ 2,32,000 minimum investment)

Aprameya Engineering financials

  • Revenue: Decrease of 16.23%
  • Profit After Tax (PAT): Decrease of 35.62%

Key considerations about the Aprameya Engineering IPO

  • Financial Performance: A recent decline in both revenue and profit raises concerns. Investors should thoroughly investigate the reasons behind this negative trend.
  • Growth Potential: The Indian healthcare sector is experiencing significant growth. However, Aprameya Engineering's future growth strategy and ability to capitalise on this trend require careful evaluation.
  • Market Landscape: The company faces competition from established players. Understanding Aprameya Engineering's competitive edge and unique offerings is crucial.
  • SME Listing: The listing on NSE SME implies lower liquidity compared to the main board. Investors should be comfortable with a less active trading environment for this IPO investment.

Aprameya Engineering IPO investment highlights

  • Experienced Player: With over 20 years of experience, Aprameya Engineering has a proven track record in the healthcare infrastructure sector.
  • Focus on Critical Care: The rising demand for ICUs and other critical care facilities presents a potential growth opportunity.
  • Turnkey Solutions: Providing a comprehensive solution from design to installation can be attractive to clients.

Conclusion

Aprameya Engineering's IPO offers investors a chance to participate in the expanding healthcare infrastructure market. However, the recent decline in financials and the SME listing format necessitate a cautious approach. A thorough analysis of the company's future prospects, competitive landscape, and risk factors is essential before making an investment decision. Consulting a financial advisor for personalised guidance is highly recommended.

Disclaimer: This blog is for informational purposes only and should not be considered as investment advice. It's advisable to consult a financial advisor before investing in any IPO.